ICDs and End-of-Life Care
- Written by
-
Lynne
Warner
Stevenson
MD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
-
Sherazi S, McNitt S, Aktas MK, et al. End-of-Life Care in Patients with Implantable Cardioverter Defibrillators: A MADIT-II Substudy [published online ahead of print June 3, 2013]. Pacing Clin Electrophysiol. doi: 10.1111/pace.12188.
-
Moss A, Zareba W, Hall W, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
-
Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure. N Engl J Med. 2005;352(3):225-237. Erratum in: N Engl J Med. 2005;352(20):2146.
-
Chen CY, Stevenson LW, Stewart GC, et al. Impact of baseline heart failure burden on post-implantable cardioverter-defibrillator mortality among Medicare beneficiaries. J Am Coll Cardiol. 2013;61(21):2142-2150.
-
Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928-1952.
-
Lampert R, Hayes DL, Annas GJ, et al. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7(7):1008-1026.